Seizure suppression by adenosine A2A receptor activation in a rat model of audiogenic brainstem epilepsy

Neuroscience Letters

Volumn 329, Issue 3, 2002, Pages 289-292

  Huber, Alexander ^a   Güttinger, Martin ^a   Möhler, Hanns ^a,b   Boison, Detlev ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

A1 receptor; A2A receptor; Adenosine; Audiogenic seizures; Epilepsy

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5' (N CYCLOPROPYL)CARBOXAMIDOADENOSINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUDIOGENIC SEIZURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TREATMENT OUTCOME;

EID: 0037031534     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00684-5     Document Type: Article

References (20)

1. Adami M., Bertorelli R., Ferri N., Foddi M.C., Ongini E. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur. J. Pharmacol. 294:1995;383-389.
2. Bruns R.F., Lu G.H., Pugsley T.A. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol. Pharmacol. 29:1986;331-346.
3. De Sarro G., De Sarro A., Di Paola E.D., Bertorelli R. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur. J. Pharmacol. 371:1999;137-145.
4. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:2001;31-55.
5. El Yacoubi M., Ledent C., Parmentier M., Daoust M., Costentin J., Vaugeois J. Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology. 40:2001;424-432.
6. Faingold C.L. The genetically epilepsy-prone rat. Gen. Pharmacol. 19:1988;331-338.
7. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
8. Huber A., Padrun V., Déglon N., Aebischer P., Möhler H., Boison D. Grafts of adenosine releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. USA. 98:2001;7611-7616.
9. Jacobson K.A., van Rhee A.M. Development of selective purinoceptor agonists and antagonists. Jacobson K.A., Jarvis M.F., Purinergic Approaches in Experimental Therapeutics. 1997;101-128 Wiley-Liss, New York.
10. Klinger M., Freissmuth M., Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell. Signal. 14:2002;99-108.
11. MacGregor D.G., Miller W.J., Stone T.W. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor. Br. J. Pharmacol. 110:1993;470-476.
12. Malhotra J., Gupta Y.K. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br. J. Pharmacol. 120:1997;282-288.
13. Mishra P.K., Dailey J.W., Reigel C.E., Tomsic M.L., Jobe P.C. Sex-specific distinctions in audiogenic convulsions exhibited by severe seizure genetically epilepsy-prone rats (GEPR-9s). Epilepsy Res. 2:1988;309-316.
14. Monopoli A., Conti A., Dionisotti S., Casati C., Camaioni E., Cristalli G., Ongini E. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine. Arzneimittelforschung. 44:1994;1305-1312.
15. Naritoku D.K., Mecozzi L.B., Aiello M.T., Faingold C.L. Repetition of audiogenic seizures in genetically epilepsy-prone rats induces cortical epileptiform activity and additional seizure behaviors. Exp. Neurol. 115:1992;317-324.
16. Nikodijevic O., Daly J.W., Jacobson K.A. Characterization of the locomotor depression produced by an A2-selective adenosine agonist. FEBS Lett. 261:1990;67-70.
17. Palmer T.M., Stiles G.L. Adenosine receptors. Neuropharmacology. 34:1995;683-694.
18. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
19. Young D., Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience. 58:1994;245-261.
20. 1-receptors underlies anticonvulsant effect of CGS21680. Eur. J. Pharmacol. 255:1994;239-243.